OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rare disease patients in India are rarely involved in international orphan drug trials
Monoswi Chakraborty, Mohua Chakraborty Choudhury, Indraneel Chakraborty, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 8, pp. e0000890-e0000890
Open Access | Times Cited: 8
Monoswi Chakraborty, Mohua Chakraborty Choudhury, Indraneel Chakraborty, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 8, pp. e0000890-e0000890
Open Access | Times Cited: 8
Showing 8 citing articles:
Orphan drug development: Challenges, regulation, and success stories
Narendra Chirmule, Huije Feng, Esha Cyril, et al.
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 6
Narendra Chirmule, Huije Feng, Esha Cyril, et al.
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 6
In Clinical Trials Registry-India, the classification of sponsors needs to be standardised
Jaishree Mendiratta, Mounika Pillamarapu, Gayatri Saberwal
Indian Journal of Medical Ethics (2023) Vol. 9, Iss. 1, pp. 11-18
Open Access | Times Cited: 4
Jaishree Mendiratta, Mounika Pillamarapu, Gayatri Saberwal
Indian Journal of Medical Ethics (2023) Vol. 9, Iss. 1, pp. 11-18
Open Access | Times Cited: 4
Navigating health policies and programs in India: exploring opportunities to improve rare disease management and orphan drug research
Sangita Mishra, Deepa Bhat, Sangita Mishra
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Sangita Mishra, Deepa Bhat, Sangita Mishra
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Representation from India in multinational, interventional, phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study
Jaishree Mendiratta, Ravi Vaswani, Gayatri Saberwal
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0284434-e0284434
Open Access | Times Cited: 2
Jaishree Mendiratta, Ravi Vaswani, Gayatri Saberwal
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0284434-e0284434
Open Access | Times Cited: 2
Clinical trial registries: The good, and the not so good
Gayatri Saberwal
Journal of Biosciences (2024) Vol. 49, Iss. 4
Closed Access
Gayatri Saberwal
Journal of Biosciences (2024) Vol. 49, Iss. 4
Closed Access
Identifying key factors for recurrence of genetic disorder: insights from Indian families with multiple affected children
K. A. Unnikrishna Menon, Vivek Agarwal
Journal of Community Genetics (2024)
Closed Access
K. A. Unnikrishna Menon, Vivek Agarwal
Journal of Community Genetics (2024)
Closed Access
Identifying Key Factors for Recurrence of Genetic Disorder: Insights from Indian Families with Multiple Affected Children
K. A. Unnikrishna Menon, Vivek Agarwal
Research Square (Research Square) (2024)
Open Access
K. A. Unnikrishna Menon, Vivek Agarwal
Research Square (Research Square) (2024)
Open Access
Orphan Drug Development Policies in India and the United States: A Comparison
Rohit Sanjaykumar Gahilod, Balamuralidhara Veeranna, Shantanu Thakre
Indian Journal of Pharmaceutical Education and Research (2023) Vol. 57, Iss. 2, pp. 329-336
Open Access | Times Cited: 1
Rohit Sanjaykumar Gahilod, Balamuralidhara Veeranna, Shantanu Thakre
Indian Journal of Pharmaceutical Education and Research (2023) Vol. 57, Iss. 2, pp. 329-336
Open Access | Times Cited: 1
